The first association between ETV6 germline variation and B-ALL was in 2015 when four studies described carriers of ETV6 variants with a median age of 11 years and clinical features of mild to moderate thrombocytopenia and 30% lifetime risk of hematologic malignancies, particularly B-ALL [44–47]. Here, ETV6 is linked to Thrombocytopenia.